Jones Financial Companies Lllp Alkermes Plc. Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Alkermes Plc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 92 shares of ALKS stock, worth $2,893. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92Holding current value
$2,893% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
176MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$915 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$573 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$371 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$252 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$217 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.17B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...